CRISPR/Cas9-Engineered HEK293T Cellular Model Harboring the Pathogenic CDKL5 c.172A>T Variant Recapitulates Core Molecular Phenotypes of CDKL5 Deficiency Disorder

Iranian Journal of Pharmaceutical Research · Published 2026-06-13 · DOI 10.5812/ijpr-172311

Free full text

Authors (4)

Fatemeh Faghihi, jafar amani, Milad Gholami, Iman Salahshourifar

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Faghihi, F., amani, j., Gholami, M., et al. (2026). CRISPR/Cas9-Engineered HEK293T Cellular Model Harboring the Pathogenic CDKL5 c.172A>T Variant Recapitulates Core Molecular Phenotypes of CDKL5 Deficiency Disorder. Iranian Journal of Pharmaceutical Research. https://doi.org/10.5812/ijpr-172311

Related articles